Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SILK | Silk Road Medical, Inc

IndexRUT P/E- EPS (ttm)-1.40 Insider Own2.00% Shs Outstand38.77M Perf Week-8.62%
Market Cap617.64M Forward P/E- EPS next Y-1.33 Insider Trans-4.57% Shs Float37.92M Perf Month-28.14%
Income-52.90M PEG- EPS next Q-0.34 Inst Own99.80% Short Float / Ratio4.04% / 1.70 Perf Quarter-53.60%
Sales162.90M P/S3.79 EPS this Y-6.90% Inst Trans-0.56% Short Interest1.53M Perf Half Y-61.85%
Book/sh4.01 P/B3.91 EPS next Y8.90% ROA-22.10% Target Price33.67 Perf Year-63.75%
Cash/sh4.78 P/C3.28 EPS next 5Y16.20% ROE-39.60% 52W Range15.94 - 58.04 Perf YTD-70.33%
Dividend- P/FCF- EPS past 5Y-19.10% ROI-21.90% 52W High-72.98% Beta1.19
Dividend %- Quick Ratio8.90 Sales past 5Y57.60% Gross Margin71.90% 52W Low-1.63% ATR0.85
Employees414 Current Ratio9.70 Sales Q/Q36.40% Oper. Margin-32.60% RSI (14)22.12 Volatility4.34% 4.32%
OptionableYes Debt/Eq0.48 EPS Q/Q20.60% Profit Margin-32.50% Rel Volume0.82 Prev Close15.98
ShortableYes LT Debt/Eq0.48 EarningsAug 01 AMC Payout- Avg Volume898.38K Price15.68
Recom2.30 SMA20-16.24% SMA50-22.65% SMA200-58.61% Volume733,182 Change-1.88%
Date Action Analyst Rating Change Price Target Change
Sep-21-23Downgrade Argus Buy → Hold
Sep-06-23Initiated Oppenheimer Outperform $30
Jul-12-23Downgrade JP Morgan Overweight → Neutral $50 → $28
Jul-12-23Downgrade BofA Securities Buy → Underperform $51 → $28
May-23-23Initiated CL King Buy $47
May-15-23Downgrade Wolfe Research Peer Perform → Underperform $27
Apr-03-23Upgrade Citigroup Neutral → Buy $50
Mar-31-23Initiated B. Riley Securities Buy $58
Mar-10-23Upgrade Citigroup Sell → Neutral $50
Feb-07-23Downgrade Wolfe Research Outperform → Peer Perform
Sep-21-23 10:06AM
Sep-04-23 04:30PM
Aug-11-23 06:19AM
Aug-03-23 04:30PM
Aug-02-23 10:21AM
09:03AM Loading…
09:03AM
Aug-01-23 05:35PM
04:30PM
04:05PM
Jul-13-23 02:25AM
Jul-12-23 12:35PM
08:57AM
Jul-11-23 04:30PM
Jun-30-23 08:31AM
May-22-23 07:09AM
06:54AM Loading…
06:54AM
May-16-23 03:28AM
May-09-23 06:25PM
05:18PM
04:05PM
May-07-23 08:54AM
May-05-23 09:00AM
May-04-23 04:30PM
Apr-26-23 04:30PM
Apr-18-23 04:30PM
Mar-31-23 10:36AM
08:11AM
Mar-27-23 09:54AM
Mar-02-23 08:29PM
Mar-01-23 07:52AM
08:05PM Loading…
Feb-28-23 08:05PM
04:05PM
Feb-07-23 09:00AM
Jan-23-23 12:00PM
Jan-09-23 07:20AM
07:05AM
Dec-30-22 12:46AM
Dec-28-22 04:30PM
Dec-22-22 11:47AM
Dec-12-22 09:15AM
Dec-05-22 12:00PM
Nov-10-22 07:36AM
Nov-08-22 07:35PM
04:05PM
Nov-03-22 04:30PM
Nov-01-22 12:35PM
Oct-25-22 04:30PM
Oct-19-22 01:27PM
Oct-18-22 07:46PM
Oct-17-22 08:03PM
04:25PM
12:53PM
Sep-29-22 07:41AM
Sep-28-22 02:25PM
Sep-07-22 04:15PM
Aug-30-22 04:15PM
Jul-27-22 09:31AM
Jul-26-22 05:35PM
04:05PM
Jul-22-22 01:26PM
Jul-12-22 04:15PM
07:07AM
Jun-15-22 09:00AM
Jun-09-22 02:29PM
Jun-02-22 07:00AM
May-31-22 09:00AM
May-10-22 11:21AM
May-04-22 07:35PM
04:05PM
May-02-22 08:30AM
Apr-26-22 04:10PM
Apr-13-22 04:15PM
Feb-24-22 05:40PM
04:01PM
08:12AM
Feb-17-22 03:03PM
Feb-03-22 04:30PM
Feb-02-22 04:30PM
Jan-27-22 10:00AM
Jan-10-22 01:11PM
Jan-07-22 05:38PM
Dec-30-21 04:30PM
Nov-25-21 09:11AM
Nov-16-21 12:22PM
Nov-10-21 04:10PM
12:31AM
Nov-09-21 06:45PM
04:05PM
Nov-03-21 11:34AM
Nov-02-21 04:10PM
03:01PM
Nov-01-21 11:38AM
Oct-21-21 04:10PM
Oct-13-21 11:42AM
Oct-11-21 03:39PM
Oct-06-21 11:30AM
Sep-30-21 11:15AM
08:50AM
Sep-29-21 12:00PM
Sep-15-21 10:50AM
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure. Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Klemz Kevin MEVP/Chief Legal Officer/Sec.Aug 17Sale20.111,53930,94238,797Aug 18 08:16 PM
Davis Andrew S.Chief Commercial OfficerAug 03Sale22.136,587145,797109,534Aug 04 05:31 PM
Buchanan Lucas W.COO/CFOJul 28Option Exercise5.429,64352,229215,725Jul 31 05:44 PM
Jones Marie L.CAO and VP, FinanceJul 20Option Exercise6.112,00012,22048,002Jul 21 06:24 PM
Rogers Erica J.President and CEOJul 11Option Exercise1.601,0001,600270,639Jul 13 06:34 PM
Rogers Erica J.President and CEOJul 11Sale31.561,00031,560269,639Jul 13 06:34 PM
Davis Andrew S.Chief Commercial OfficerJul 06Sale30.79692,124115,614Jul 10 05:39 PM
Rogers Erica J.President and CEOJun 12Option Exercise1.601,0001,600270,639Jun 13 08:13 PM
Rogers Erica J.President and CEOJun 12Sale32.131,00032,130269,639Jun 13 08:13 PM
Rogers Erica J.President and CEOMay 11Option Exercise1.603,0004,800272,132May 12 09:37 PM
Rogers Erica J.President and CEOMay 11Sale35.513,000106,530269,132May 12 09:37 PM
Davis Andrew S.Chief Commercial OfficerMay 01Option Exercise5.906,75339,845122,436May 03 06:39 PM
Davis Andrew S.Chief Commercial OfficerMay 01Sale44.516,753300,593115,683May 03 06:39 PM
WEATHERMAN ELIZABETH HDirectorApr 17Sale41.915,000209,550144,454Apr 19 06:14 PM
Rogers Erica J.President and CEOApr 11Option Exercise1.606,0009,600275,132Apr 12 05:29 PM
Rogers Erica J.President and CEOApr 11Sale39.776,000238,635269,132Apr 12 05:29 PM
Davis Andrew S.Chief Commercial OfficerApr 03Option Exercise4.796,75332,372122,436Apr 05 05:19 PM
Davis Andrew S.Chief Commercial OfficerApr 03Sale39.426,753266,203115,683Apr 05 05:19 PM
WEATHERMAN ELIZABETH HDirectorMar 15Sale41.915,000209,550149,454Mar 17 07:06 PM
Rogers Erica J.President and CEOMar 13Option Exercise1.606,0009,600275,132Mar 15 06:16 PM
Rogers Erica J.President and CEOMar 13Sale42.236,000253,393269,132Mar 15 06:16 PM
Davis Andrew S.Chief Commercial OfficerMar 06Sale47.743,868184,653115,683Mar 06 08:19 PM
Ruedy RichardEVPClin&Reg.Affairs&QAMar 06Sale47.732,373113,257145,483Mar 06 08:20 PM
Rogers Erica J.President and CEOMar 03Sale47.1018,043849,901269,132Mar 06 08:14 PM
Buchanan Lucas W.COO/CFOMar 03Sale47.119,918467,193205,575Mar 06 08:17 PM
Davis Andrew S.Chief Commercial OfficerMar 01Option Exercise4.736,75331,942104,144Mar 02 09:01 PM
Davis Andrew S.Chief Commercial OfficerMar 01Sale48.026,753324,27298,205Mar 02 09:01 PM
WEATHERMAN ELIZABETH HDirectorFeb 15Sale49.865,000249,300154,454Feb 17 06:56 PM
Rogers Erica J.President and CEOFeb 13Option Exercise1.606,0009,600252,199Feb 15 06:18 PM
Rogers Erica J.President and CEOFeb 13Sale50.946,000305,627246,199Feb 15 06:18 PM
Davis Andrew S.Chief Commercial OfficerFeb 01Option Exercise4.736,75331,942104,958Feb 03 07:19 PM
Chou Tony M.DirectorFeb 01Sale55.0013,008715,44075,707Feb 03 07:14 PM
Davis Andrew S.Chief Commercial OfficerFeb 01Sale54.056,753365,00098,205Feb 03 07:19 PM
Buchanan Lucas W.COO/CFOJan 19Option Exercise13.9038,528535,666217,289Jan 19 08:01 PM
Buchanan Lucas W.COO/CFOJan 19Sale53.4041,2442,202,533188,811Jan 19 08:01 PM
Buchanan Lucas W.COO/CFOJan 17Option Exercise1.6045,00072,000236,527Jan 19 08:01 PM
WEATHERMAN ELIZABETH HDirectorJan 17Sale54.6956,3553,082,224159,454Jan 19 06:44 PM
Buchanan Lucas W.COO/CFOJan 17Sale54.6845,0002,460,622191,527Jan 19 08:01 PM
Chou Tony M.DirectorJan 13Sale55.0080644,33087,709Jan 17 06:07 PM
Chou Tony M.DirectorJan 12Sale55.0020011,00088,515Jan 17 06:07 PM
Rogers Erica J.President and CEOJan 11Option Exercise1.606,0009,600252,199Jan 13 05:32 PM
Rogers Erica J.President and CEOJan 11Sale51.536,000309,180246,199Jan 13 05:32 PM
Davis Andrew S.Chief Commercial OfficerJan 03Option Exercise2.336,75315,744103,380Jan 04 08:03 PM
Davis Andrew S.Chief Commercial OfficerJan 03Sale52.876,753357,03198,205Jan 04 08:03 PM
Buchanan Lucas W.COO/CFODec 15Option Exercise1.6015,00024,000191,527Dec 15 08:35 PM
Buchanan Lucas W.COO/CFODec 13Option Exercise1.6025,00040,000201,527Dec 15 08:35 PM
Buchanan Lucas W.COO/CFODec 13Sale55.0025,0001,375,000176,527Dec 15 08:35 PM
Chou Tony M.DirectorDec 13Sale55.0010,060553,30088,715Dec 15 07:00 PM
Rogers Erica J.President and CEODec 12Option Exercise1.6010,00016,000256,199Dec 14 07:04 PM
Rogers Erica J.President and CEODec 12Sale53.8510,000538,501246,199Dec 14 07:04 PM
Davis Andrew S.Chief Commercial OfficerDec 01Option Exercise1.556,75310,457102,472Dec 02 06:40 PM
Davis Andrew S.Chief Commercial OfficerDec 01Sale53.006,753357,90998,205Dec 02 06:40 PM
Buchanan Lucas W.COO/CFONov 11Option Exercise1.6024,80039,680201,327Nov 14 06:24 PM
Rogers Erica J.President and CEONov 11Option Exercise1.6010,00016,000256,199Nov 14 06:27 PM
Buchanan Lucas W.COO/CFONov 11Sale50.0024,8001,240,000176,527Nov 14 06:24 PM
Rogers Erica J.President and CEONov 11Sale50.0310,000500,309246,199Nov 14 06:27 PM
Buchanan Lucas W.COO/CFONov 09Option Exercise1.60200320176,727Nov 14 06:24 PM
Buchanan Lucas W.COO/CFONov 09Sale50.0020010,000176,527Nov 14 06:24 PM
Davis Andrew S.Chief Commercial OfficerNov 01Option Exercise1.466,7539,859104,958Nov 01 07:48 PM
Davis Andrew S.Chief Commercial OfficerNov 01Sale44.176,753298,28098,205Nov 01 07:48 PM
Rogers Erica J.President and CEOOct 11Option Exercise1.6010,00016,000256,199Oct 13 06:58 PM
Rogers Erica J.President and CEOOct 11Sale42.3210,000423,218246,199Oct 13 06:58 PM
Davis Andrew S.Chief Commercial OfficerOct 03Option Exercise1.466,7539,859104,958Oct 05 08:36 PM
Davis Andrew S.Chief Commercial OfficerOct 03Sale44.766,753302,26498,205Oct 05 08:36 PM